Talk to the analystsTalk to us
Language: EN
Talk to the analysts

Press

  1. Baladna Q.P.S.C.: The Raise, the Costs and the Half Year

  2. Zaptec ASA: The Share Price Now Pays for the Chargers, Not Yet for the Service on Them

  3. Sirnaomics Ltd.: The RNAimmune Money Is In, and the FDA Has Answered in Writing on STP705

  4. Ainos, Inc.: A Partner Pays for VELDONA, and Ainos Keeps the Platform

  5. Ainos Inc: A Front-End Customer Starts Ordering, and the Dataset Passes a Billion

  6. Ainos, Inc.: Three Patents Approved in Japan, and a Dataset Gathering Pace

  7. Baladna: The Capital Is Raised, Algeria Is Building – VASRO Reiterates BUY at QAR 2.33

  8. Sirnaomics Ltd.: Every Approved siRNA Drug Works in the Liver. This One Was Injected Into Skin Cancer. VASRO Initiates Coverage With BUY

  9. Zaptec ASA: Europe’s Largest AC Charging Brand, With the Service Layer Priced at Zero – VASRO Initiates Coverage With BUY

  10. Spinneys 1961 Holding PLC: The Estate Grew 17%, Demand Did Not — First Half 2026 Update